Cardiocast

AHA statement on statin risks, app that diagnoses STEMI, and more


 

This week, the American Heart Association says that statins’ benefits far outweigh the risks, a smartphone app is nearly as good as an ECG at diagnosing STEMI, stroke thrombolysis appears safe in patients prone to GI bleeding, and a new strategy for pausing DOAC therapy works in A-fib patients.

Subscribe to Cardiocast wherever you get your podcasts.
Amazon Alexa
Apple Podcasts

Recommended Reading

Children with poor cardiorespiratory fitness have a higher risk of type 2 diabetes and cardiovascular disease
MDedge Cardiology
Empagliflozin reduces left ventricular mass
MDedge Cardiology
‘Phenomenal’ REDUCE-IT establishes triglyceride theory
MDedge Cardiology
Omega-3 fatty acid supplementation reduces risk of preterm birth
MDedge Cardiology
Visual representation of atherosclerosis helps reduce cardiovascular risk
MDedge Cardiology
People with HIV still at increased cardiovascular risk
MDedge Cardiology
Combined novel risk factors raise coronary event rates
MDedge Cardiology
Study investigates statin-diabetes link
MDedge Cardiology
AHA: Statins associated with high degree of safety
MDedge Cardiology
Obesity meds used by just over half of pediatric obesity programs
MDedge Cardiology